Back to Market Feed

Product Information

RETACRIT 20,000 UNIT/ML VIAL is a brand biologic product labeled by Pfizer Inc., priced at $224.7876 per ML under NDC 00069131110. Its NADAC has been published 49 times since Sep 17, 2025.

RETACRIT 20,000 UNIT/ML VIAL

epoetin alfa-epbx
$224.7876per ML

Strength

20000 [iU]/mL

Manufacturer

Pfizer Inc.

NDC

00069131110

Classification

Brand Biologic

Dosage Form

INJECTION, SOLUTION

Route

INTRAVENOUS; SUBCUTANEOUS

Effective Date

7/1/2026

Active Ingredients

EPOETIN

Approval Type

Biologic (BLA)

FDA Application

BLA125545

On Market Since

11/9/2020

Pharmacological Classes

Erythropoiesis-stimulating Agent
Erythropoietin
Increased Erythroid Cell Production

Price Statistics

The NADAC for RETACRIT 20,000 UNIT/ML VIAL has been published 49 times since Sep 17, 2025, and over the history we have for it it has risen 5.1%. The table below summarizes its recorded NADAC range and movement.

Current price$224.7876 per ML
All-time high$224.7876 (Aug 19, 2026)
All-time low$213.7798 (Sep 17, 2025)
52-week high$224.7876
52-week low$213.7798
Median price$219.3906
Average price$218.5682
Largest weekly change+2.5% (Jul 1, 2026)
Weeks tracked49
Tracking sinceSep 17, 2025

Price History

1W

0.0%

1M

0.0%

3M

+2.5%

6M

+2.5%

1Y

N/A

3Y

N/A

5Y

N/A

All

+5.1%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the epoetin alfa-epbx market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

No related drugs found.

Frequently asked questions

What is the NADAC price of RETACRIT 20,000 UNIT/ML VIAL?

The current National Average Drug Acquisition Cost (NADAC) for RETACRIT 20,000 UNIT/ML VIAL, manufactured by Pfizer Inc., is $224.7876 per ML (NDC 00069131110), effective Aug 19, 2026.

How has the price of RETACRIT 20,000 UNIT/ML VIAL changed over time?

Over the history we have for it, the NADAC for RETACRIT 20,000 UNIT/ML VIAL has risen 5.1%. It has been tracked across 49 weekly CMS publications since Sep 17, 2025.

What are the highest and lowest recorded NADAC prices for RETACRIT 20,000 UNIT/ML VIAL?

Since Sep 17, 2025, the NADAC for RETACRIT 20,000 UNIT/ML VIAL has ranged from a low of $213.7798 (Sep 17, 2025) to a high of $224.7876 (Aug 19, 2026), with a median of $219.3906 per ML.

Are there cheaper alternatives to RETACRIT 20,000 UNIT/ML VIAL?

No other NADAC-published product currently shares the active ingredient and strength of RETACRIT 20,000 UNIT/ML VIAL in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures RETACRIT 20,000 UNIT/ML VIAL?

RETACRIT 20,000 UNIT/ML VIAL (NDC 00069131110) is labeled by Pfizer Inc., and CMS classifies it as a brand biologic product.